372 related articles for article (PubMed ID: 20885341)
1. Seasonal trivalent influenza vaccine for 2010-2011.
Med Lett Drugs Ther; 2010 Oct; 52(1348):77-9. PubMed ID: 20885341
[No Abstract] [Full Text] [Related]
2. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
[TBL] [Abstract][Full Text] [Related]
3. Using surveillance to evaluate influenza vaccine effectiveness.
Jackson LA
J Infect Dis; 2009 Jan; 199(2):155-8. PubMed ID: 19086916
[No Abstract] [Full Text] [Related]
4. Selection bias in evaluating of influenza vaccine effectiveness: a lesson from an observational study of elderly nursing home residents.
Fukushima W; Hayashi Y; Mizuno Y; Suzuki K; Kase T; Ohfuji S; Fujieda M; Maeda A; Hirota Y
Vaccine; 2008 Nov; 26(50):6466-9. PubMed ID: 18582520
[TBL] [Abstract][Full Text] [Related]
5. Influenza vaccine 2008-2009.
Med Lett Drugs Ther; 2008 Oct; 50(1296):77-9. PubMed ID: 18833032
[TBL] [Abstract][Full Text] [Related]
6. Low-dose intradermal versus intramuscular trivalent inactivated seasonal influenza vaccine in lung transplant recipients.
Manuel O; Humar A; Berutto C; Ely L; Giulieri S; Lien D; Meylan PR; Weinkauf J; Pascual M; Nador R; Aubert JD; Kumar D
J Heart Lung Transplant; 2011 Jun; 30(6):679-84. PubMed ID: 21377898
[TBL] [Abstract][Full Text] [Related]
7. [The influenza season 2004/'05 in the Netherlands with the largest epidemic of the last 5 years caused by the virus variant A/California and the composition of the vaccine for the season 2005/'06].
de Jong JC; Rimmelzwaan GF; Bartelds AI; Meijer A; Fouchier RA; Osterhaus AD
Ned Tijdschr Geneeskd; 2005 Oct; 149(42):2355-61. PubMed ID: 16261717
[TBL] [Abstract][Full Text] [Related]
8. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
Skowronski DM; De Serres G; Dickinson J; Petric M; Mak A; Fonseca K; Kwindt TL; Chan T; Bastien N; Charest H; Li Y
J Infect Dis; 2009 Jan; 199(2):168-79. PubMed ID: 19086914
[TBL] [Abstract][Full Text] [Related]
9. Possible reduced effectiveness of the 2009 H1N1 component of live, attenuated influenza vaccine.
Myers CA; Faix DJ; Blair PJ
Clin Infect Dis; 2011 Jul; 53(2):207-8. PubMed ID: 21690631
[No Abstract] [Full Text] [Related]
10. Safety and immunogenicity of a trivalent single dose seasonal influenza vaccine containing pandemic A(H1N1) antigen in younger and elderly subjects: a phase III open-label single-arm study.
Loebermann M; Anders G; Brestrich G; Fritzsche C; Klammt S; Boršo D; Frimmel S; Riebold D; Reisinger EC
Vaccine; 2011 Feb; 29(6):1228-34. PubMed ID: 21167116
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results.
Andrews N; McMenamin J; Durnall H; Ellis J; Lackenby A; Robertson C; von Wissmann B; Cottrell S; Smyth B; Moore C; Gunson R; Zambon M; Fleming D; Pebody R
Euro Surveill; 2014 Jul; 19(27):5-13. PubMed ID: 25033051
[TBL] [Abstract][Full Text] [Related]
12. Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care.
Vesikari T; Fleming DM; Aristegui JF; Vertruyen A; Ashkenazi S; Rappaport R; Skinner J; Saville MK; Gruber WC; Forrest BD;
Pediatrics; 2006 Dec; 118(6):2298-312. PubMed ID: 17142512
[TBL] [Abstract][Full Text] [Related]
13. [The 50% effective dose (ED50a) of seasonal spilt influenza vaccine in mice].
Huang BY; Wang XP; Tang WJ; Wang WL; Ruan L
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Apr; 25(2):92-5. PubMed ID: 21863626
[TBL] [Abstract][Full Text] [Related]
14. [The 2005-2006 influenza season in the Netherlands and the vaccine composition for the 2006-2007 season].
Rimmelzwaan GF; de Jong JC; Donker GA; Meijer A; Fouchier RA; Osterhaus AD
Ned Tijdschr Geneeskd; 2006 Oct; 150(40):2209-14. PubMed ID: 17061434
[TBL] [Abstract][Full Text] [Related]
15. Recommendations for prevention and control of influenza in children, 2013-2014.
Committee on infectious diseases
Pediatrics; 2013 Oct; 132(4):e1089-104. PubMed ID: 23999962
[TBL] [Abstract][Full Text] [Related]
16. Recommendations for prevention and control of influenza in children, 2012-2013.
Committee on Infectious Diseases, American Academy of Pediatrics
Pediatrics; 2012 Oct; 130(4):780-92. PubMed ID: 22966032
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B;
Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278
[TBL] [Abstract][Full Text] [Related]
18. Policy statement--recommendations for prevention and control of influenza in children, 2010-2011.
American Academy of Pediatrics. Committee on Infectious Diseases
Pediatrics; 2010 Oct; 126(4):816-26. PubMed ID: 20805143
[TBL] [Abstract][Full Text] [Related]
19. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
[TBL] [Abstract][Full Text] [Related]
20. Rapid decline of influenza vaccine-induced antibody in the elderly: is it real, or is it relevant?
Skowronski DM; Tweed SA; De Serres G
J Infect Dis; 2008 Feb; 197(4):490-502. PubMed ID: 18275271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
